Opportunity timeline
In plain English
Los Alamos National Laboratory is offering licensing for DC Recruiter, a self-assembling peptide nanofiber designed to recruit and activate dendritic cells for broad, early immune support against infections. The concept is needle-free and spray-friendly, with potential uses in outbreak response, defense, emergency preparedness, pharmaceuticals and consumer health. The technology is at TRL 3, has a US patent pending, and is available through exclusive or non-exclusive licensing agreements; this is not a request for development services.
About this opportunity
DC Recruiter: Broad-Spectrum Immune Enhancer from scientists at Los Alamos National Laboratory offers a differentiated approach to multi-pathogen infection prevention by using a self-assembling peptide nanofiber to recruit and activate dendritic cells (DCs), the immune system’s natural sentinels. Unlike pathogen-specific vaccines or therapeutics, it is designed to help trigger an early immune response regardless of the infecting agent. Its needle-free, spray-friendly concept adds practicality. The Challenge: DC Recruiter addresses a persistent and highly consequential gap in infection management: the need for a rapid, broadly effective way to stimulate immune defense before the specific…
Time remaining
Closes Dec 16, 2026
Related Opportunities

DARPA Surgical Competition (DSC) Industry Day

Cryo-Electron Microscopy (Cryo-EM) Services

Human Hindbrain Organoid Functional Assay Services.

Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)

Study entitled “Malaria and vector borne disease surveillance in the Colombia/Venezuela border”
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-CCA5D7

